Finland· FI-REL-REL63692
Symtuza
A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing darunavir ethanolate + cobicistat + emtricitabine + tenofovir alafenamide fumarate, registered in Finland by Janssen-Cilag International NV. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Darunavir ethanolate + Cobicistat + Emtricitabine + Tenofovir alafenamide fumarate
- Manufacturer
- Janssen-Cilag International NV
- Country
- Finland (FI)
- ATC code
- J05AR22
- ATC class
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSYMTUZAJanssen-Cilag International N.V., Beerse
- IrelandSymtuza 800 mg/150 mg/200 mg/10 mg film-coated tabletsJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/00f35eac-c341-49df-a713-1df0514eca20 GET /v1/drugs/00f35eac-c341-49df-a713-1df0514eca20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "675 mg / 150 mg / 200 mg / 10 mg",
"atc_label": "emtrisitabiini, tenofoviirialafenamidi, darunaviiri ja kobisistaatti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/17/1225/003",
"fimea_rel_id": "REL63692",
"authorised_at": "2026-09-03"
}See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.